nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
295 Accumulation of 53BP1 in circulating tumor cells during treatment with eribulin identifies chemotherapy-responsive metastatic breast cancer patients
|
Schochter, Fabienne |
|
|
30 |
S4 |
p. A98 |
artikel |
2 |
393 A clinical audit of molar pregnancies and gestational trophoblastic neoplasia cases over 1yr in a tertiary care hospital of Eastern India with respect to the incidence of disease, factors related to etiopathogenesis, diagnosis and management
|
Banerjee, Swarnabindu |
|
|
30 |
S4 |
p. A99-A100 |
artikel |
3 |
195 A clinical study on the application of 3D-printing minimally invasive-guided template in brachytherapy of patients with locally advanced cervical cancer
|
Yuan, Xiangkun |
|
|
30 |
S4 |
p. A6-A7 |
artikel |
4 |
437 Adrenal incidentalomas in gynaecology oncology surgical patients: timely investigation and management avoiding undue delays to oncological surgery
|
Grant, Marie-Therese |
|
|
30 |
S4 |
p. A53 |
artikel |
5 |
527 Analysis of uterine lavage for early ovarian cancer detection
|
Zilovic, Diana |
|
|
30 |
S4 |
p. A113-A114 |
artikel |
6 |
165 An audit of the use of vaginal brachytherapy in endometrial cancers
|
Ilangovan, Bhargavi |
|
|
30 |
S4 |
p. A30-A31 |
artikel |
7 |
310 A new proposal for the clinical classification of vulvar lichen sclerosus: an observational prospective study
|
Boero, Veronica |
|
|
30 |
S4 |
p. A24-A25 |
artikel |
8 |
606 Angiomyofibroblastoma vulvar: case report and literature review
|
Buitrago, Sandra Marcela |
|
|
30 |
S4 |
p. A132 |
artikel |
9 |
609 Angiomyofibroblastoma vulvar: case report and literature review
|
Buitrago, Sandra Marcela |
|
|
30 |
S4 |
p. A133 |
artikel |
10 |
585 A pilot study for the validation of sentinel lymph node biopsy with indocyanine green fluorescence method in early endometrial cancer at Fundación Jiménez Díaz university hospital
|
Villayzan, José García |
|
|
30 |
S4 |
p. A119-A120 |
artikel |
11 |
622 Applicability of duke activity scale index (DASI) in perioperative prediction of postoperative complications for gynaeoncology patients
|
Sevinyan, Lusine |
|
|
30 |
S4 |
p. A134-A135 |
artikel |
12 |
596 A randomised phase II study of nintedanib (BIBF1120) compared to chemotherapy in patients with recurrent clear cell carcinoma of the ovary or endometrium. (NICCC/ENGOT-OV36)
|
Glasspool, Rosalind |
|
|
30 |
S4 |
p. A127-A128 |
artikel |
13 |
316 ‘Are there limits to curative treatments?’ – The impact of chemo-radiation in cervical cancer patients
|
Alpoim, Tiago |
|
|
30 |
S4 |
p. A11 |
artikel |
14 |
551 A retrospective study of sternal metastases in breast cancer
|
Ghomari, Cherifa Fazila |
|
|
30 |
S4 |
p. A2 |
artikel |
15 |
595 Assessing trends in stage and outcomes of uterine cervix cancer in an opportunistic screening setting
|
Cruz Lugarinho, Priscila Tavares |
|
|
30 |
S4 |
p. A116 |
artikel |
16 |
369 A systematic review to identify and assess the mental health sequalae amongst women with endometriosis with or without chronic pelvic pain (THE ELEMI PROJECT)
|
Hapangama, Dharani |
|
|
30 |
S4 |
p. A52-A53 |
artikel |
17 |
194 Ataxia-teleangiectasia followed up in a hereditary gynaecological cancer unit of a tertiary hospital
|
Veiga-Fernández, Amanda |
|
|
30 |
S4 |
p. A91-A92 |
artikel |
18 |
505 Attitudes towards risk reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study
|
Gaba, Faiza |
|
|
30 |
S4 |
p. A93-A94 |
artikel |
19 |
Author index
|
|
|
|
30 |
S4 |
p. 136-141 |
artikel |
20 |
556 Axillary lymphadenectomy vs. sentinel node biopsy for early-stage clinically node-negative breast cancer: a systematic review and meta-analysis
|
Petousis, Stamatios |
|
|
30 |
S4 |
p. A2-A3 |
artikel |
21 |
554 Biopsar study: ultrasound-guided preoperative biopsy to assess histology of sarcoma-suspicious uterine tumors. a new study protocol
|
Petousis, Stamatios |
|
|
30 |
S4 |
p. A113 |
artikel |
22 |
261 BRCA1/2 mutations predict better survival in high-grade endometrioid endometrial cancer
|
Dai, Yibo |
|
|
30 |
S4 |
p. A32 |
artikel |
23 |
229 Breast cancer patients at increased risk of developing type II endometrial cancer; relative and absolute risk estimation and implications for genetic counselling
|
Laios, Alexandros |
|
|
30 |
S4 |
p. A92 |
artikel |
24 |
411 Cancer cell stemness and collagen regulators of stemness in uterine serous carcinoma (USC) mirror ovarian serous cancer (OSC) cell stemness: evidence emerging from ARK1-USC
|
Hanauske-Abel, Hartmut |
|
|
30 |
S4 |
p. A41 |
artikel |
25 |
197 Can D-dimers and fibrinogen aid in the diagnosis of ovarian cancer?
|
Mckendry, Kate |
|
|
30 |
S4 |
p. A57 |
artikel |
26 |
139 Centre of hereditary breast and ovarian cancer at charité – who presents for counseling and why?
|
Helms, Malina |
|
|
30 |
S4 |
p. A109 |
artikel |
27 |
193 Cervical oncological cytologies’s (PAP test) evaluation of the riverine women from rivers tapajós and cupari (Pará – Brazil)
|
Lima Ferrero, Maria Vitoria |
|
|
30 |
S4 |
p. A6 |
artikel |
28 |
383 Changes in the proteome of cervicovaginal fluid during HPV infection in hpv-vaccinated women
|
Iurova, Mariia |
|
|
30 |
S4 |
p. A15-A16 |
artikel |
29 |
320 Charlson comorbidity index as a factor impacting survival among ovarian cancer patients – results from a systematic review
|
Asthana, Smita |
|
|
30 |
S4 |
p. A66-A67 |
artikel |
30 |
441 Chemotherapy response score: correlation with preoperative serological and radiological assessment of response and clinical implications in ovarian cancer patients
|
Ramspott, Jan Philipp |
|
|
30 |
S4 |
p. A83 |
artikel |
31 |
599 Circulating tumour cells in breast and ovarian cancer: size-based isolation and ex vivo expansion
|
Mohamed, Bashir |
|
|
30 |
S4 |
p. A131-A132 |
artikel |
32 |
314 Clinical characteristics and prognosis of ovarian clear cell carcinoma: a 10-year retrospective study
|
Zhu, Chenchen |
|
|
30 |
S4 |
p. A66 |
artikel |
33 |
576 Clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma of the cervix, a local study
|
Yu, Marilou |
|
|
30 |
S4 |
p. A114 |
artikel |
34 |
345 Clinical parameters predicting risk of concurrent invasive carcinoma and high-risk carcinoma in patients with endometrial intraepithelial neoplasia
|
Orhan, Nazlı |
|
|
30 |
S4 |
p. A36 |
artikel |
35 |
615 Clinic-pathological features of mixed endometrial carcinoma; evaluation of 29 patients in a single tertiary center
|
Sucu, Mete |
|
|
30 |
S4 |
p. A122-A123 |
artikel |
36 |
509 Combitec: multicentric retrospective study on sentinel lymph node detection by combined icg + 99MTC versus exclusive icg in endometrial cancer
|
Conesa, Vicente Bebia |
|
|
30 |
S4 |
p. A44 |
artikel |
37 |
382 Comparison of the efficacy of reiki versus sport as supportive care during neoadjuvant chemotherapy of early breast cancer: sub analysis of the randomized controlled reassure (Reiki as supportive treatment during chemotherapy of breast cancer) study
|
Zander, Lena |
|
|
30 |
S4 |
p. A1 |
artikel |
38 |
608 Comparison of topical treatment of cervical squamous intraepithelial lesionswith imiquimod with standard excisional technique using LLETZ: a randomized controlled trial
|
Cokan, Andrej |
|
|
30 |
S4 |
p. A117 |
artikel |
39 |
330 Complete surgical cytoreduction remains pivotal in achieving better survival outcomes in patients with advanced ovarian cancer with a BRCA1/2 germline mutation in the pre-parp inhibitor ERA
|
Otify, Mohamed |
|
|
30 |
S4 |
p. A67 |
artikel |
40 |
525 Concurrent chemoradiotherapy followed by surgery for cervical cancer: a multicenter retrospective study of 126 cases
|
Fouad, Asmàa |
|
|
30 |
S4 |
p. A22-A23 |
artikel |
41 |
108 Conditional relative survival of ovarian cancer : a korean national cancer registry study
|
Bae, Jaeman |
|
|
30 |
S4 |
p. A55-A56 |
artikel |
42 |
78 Contralateral non-sentinel node metastasis in early primary vulvar cancer women with positive unilateral sentinel node
|
Winarno, Andreas Suhartoyo |
|
|
30 |
S4 |
p. A102 |
artikel |
43 |
257 Contrasting clinical characteristics and treatment patterns in women with newly diagnosed advanced-stage ovarian cancer in Australia, South Korea and Taiwan
|
Chou, Hung-Hsueh |
|
|
30 |
S4 |
p. A59-A60 |
artikel |
44 |
258 Design and validation of a recurrence risk predicting score in early stage cervical cancer after radical hysterectomy
|
Manzour, Nabil |
|
|
30 |
S4 |
p. A8 |
artikel |
45 |
619 Detecting cervical dysplasia with folate receptor-mediated detection staining agent
|
Roškar, Luka |
|
|
30 |
S4 |
p. A118 |
artikel |
46 |
443 Detection of the sentinel lymph node by ecoguided myometrial injection (TUMIR) of radiotracer versus hybrid tracer (RADIOTRACER-ICG) in patients with intermediate/high risk endometrial cancer
|
Agustí, Núria |
|
|
30 |
S4 |
p. A41-A42 |
artikel |
47 |
54 Diagnostic accuracy of serum insulin-like growth factor binding protein 2 for ovarian cancer
|
Aditya Prayudi, Pande Kadek |
|
|
30 |
S4 |
p. A54 |
artikel |
48 |
311 Diagnostic value of HE4, CA-125, roma and cph-i for preoperative assessment of ovarian tumors
|
Diéguez, Núria Carreras |
|
|
30 |
S4 |
p. A25-A26 |
artikel |
49 |
256 Differences in immune-related adverse events between vulvovaginal vs. cutaneous melanoma: a retrospective cohort study
|
Naderi-Azad, Sheida |
|
|
30 |
S4 |
p. A104 |
artikel |
50 |
154 Disease-free survival in early-stage cervical cancer: comparison of laparoscopic versus open surgery in a tertiary centre
|
Veiga-Fernández, Amanda |
|
|
30 |
S4 |
p. A5-A6 |
artikel |
51 |
86 3D-printed multi-channel vaginal applicator for brachytherapy in gynecological cancer
|
Logar, Helena |
|
|
30 |
S4 |
p. A102-A103 |
artikel |
52 |
552 Dual cervical and fundal injection in endometrial cancer
|
Gorostidi, Mikel |
|
|
30 |
S4 |
p. A46 |
artikel |
53 |
577 Early salpingectomy (tubectomy) with delayed oophorectomy as an alternative for risk-reducing salpingo-oophorectomy to improve quality of life in women with a BRCA1/2 pathogenic variant (tuba study): a prospective multicenter preference trial
|
Steenbeek, Miranda P |
|
|
30 |
S4 |
p. A128-A129 |
artikel |
54 |
589 Early stage, low grade endometrial adenocarcinoma in reproductive aged women. an evaluation of patient perspectives of diagnosis, treatment decision making, management, fertility and survivorship: a qualitative study
|
Roman, Alina |
|
|
30 |
S4 |
p. A120-A121 |
artikel |
55 |
498 Edmond: a feasibility study of elemental diet as an alternative to parenteral nutrition for ovarian cancer patients with inoperable malignant bowel obstruction
|
Michael, Agnieszka |
|
|
30 |
S4 |
p. A85 |
artikel |
56 |
476 Effectiveness of photodynamic therapy in lichen sclerosus with neoplastic background
|
Bizoń-Szpernalowska, Magdalena |
|
|
30 |
S4 |
p. A97 |
artikel |
57 |
611 Effect of sentinel lymph node biopsy on upper limb function in women with early breast cancer: a systematic review of clinical trials
|
Pilger, Taynara Louisi |
|
|
30 |
S4 |
p. A114 |
artikel |
58 |
326 Effects of local laser treatment on vulvovaginal atrophy for women with breast cancer: a prospective study with long-term follow-up
|
Veron, Lucie |
|
|
30 |
S4 |
p. A96 |
artikel |
59 |
347 Efficacy and safety of niraparib in older patients (PTS) with advanced ovarian cancer (OC): results from the prima/ENGOT-OV26/GOG-3012 trial
|
Dahlstrand, Hanna |
|
|
30 |
S4 |
p. A69-A70 |
artikel |
60 |
288 Efficacy of a multi-ingredient coriolus versicolor-based vaginal gel in high-risk HPV+ patients: results of different studies
|
Gaslain, Yann |
|
|
30 |
S4 |
p. A10 |
artikel |
61 |
285 Efficacy of a multi-ingredient coriolus versicolor-based vaginal gel in HPV+ women older than 40 years: sub-analysis of paloma clinical trial
|
Gaslain, Yann |
|
|
30 |
S4 |
p. A9 |
artikel |
62 |
388 Efficacy of individualised starting dose (ISD) and fixed starting dose (FSD) of niraparib per investigator assessment (IA) in newly diagnosed advanced ovarian cancer (OC) patients
|
Peen, Ulla |
|
|
30 |
S4 |
p. A90-A91 |
artikel |
63 |
364 Efficacy of niraparib therapy in patients with newly diagnosed advanced ovarian cancer by brcawt status: prima/ENGOT-OV26/GOG-3012 study
|
Braicu, Elena Ioana |
|
|
30 |
S4 |
p. A70-A71 |
artikel |
64 |
416 Elucidating resistance mechanism to parp inhibitors for the development of novel therapeutic approaches in high-grade serous ovarian cancer
|
Kulbe, Hagen |
|
|
30 |
S4 |
p. A79 |
artikel |
65 |
357 Endometrial biopsies: for whom and when?
|
Temiz, Bilal Esat |
|
|
30 |
S4 |
p. A36-A37 |
artikel |
66 |
492 Endometrial cancer: the role of prognostic factors and their impact on recurrence pattern
|
Parpinel, Giulia |
|
|
30 |
S4 |
p. A43 |
artikel |
67 |
387 ENGOT-EN6/GOG-3031/NSGO-RUBY: a phase 3, randomised, double-blind, multicenter study of dostarlimab + carboplatin-paclitaxel versus placebo + carboplatin-paclitaxel in recurrent or primary advanced endometrial cancer (EC)
|
Mirza, Mansoor R |
|
|
30 |
S4 |
p. A112 |
artikel |
68 |
559 Enhanced recovery after surgery (ERAS) for para-aortic lymphadenectomy-a new trend to consider?
|
Masquin, Isabelle |
|
|
30 |
S4 |
p. A24 |
artikel |
69 |
575 Epidemiology of ovarian cancer in kazakhstan (2013–2018)
|
Kaidarova, Dilyara |
|
|
30 |
S4 |
p. A126 |
artikel |
70 |
439 Epidemiology of ovarian cancer in kazakhstan (2013–2018)
|
Kaidarova, Dilyara |
|
|
30 |
S4 |
p. A82 |
artikel |
71 |
200 Evaluation of a proposed trastuzumab biosimilar compared with trastuzumab in neoadjuvant breast cancer treatment
|
Vitorino, Marina |
|
|
30 |
S4 |
p. A1 |
artikel |
72 |
584 Evaluation of micro-RNA expression in cytological smears in women with low grade squamous intraepithelial lesions
|
Prisyazhnaya, Tatyana |
|
|
30 |
S4 |
p. A118 |
artikel |
73 |
159 Evaluation of psychological distress and desire for psychosocial support in gynaecological cancer patients using the QSC-R10
|
Rudolph, Katharina |
|
|
30 |
S4 |
p. A96 |
artikel |
74 |
111 Evaluation of survival outcomes from delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer
|
Yao, Shih-Ern |
|
|
30 |
S4 |
p. A56 |
artikel |
75 |
366 Feasibility study of a network meta-analysis and unanchored population-adjusted indirect treatment comparison of niraparib, olaparib, and bevacizumab as maintenance therapies in patients with newly diagnosed advanced ovarian cancer
|
Lorusso, Domenica |
|
|
30 |
S4 |
p. A71-A72 |
artikel |
76 |
532 Fertility and pregnancy outcomes after fertility-sparing treatment in ovarian cancer patients
|
Sorbi, Flavia |
|
|
30 |
S4 |
p. A87 |
artikel |
77 |
558 Fertility-sparing treatment for early stage cervical cancer: a single center experience with conization and nodal evaluation
|
Martinelli, Fabio |
|
|
30 |
S4 |
p. A48-A49 |
artikel |
78 |
227 Fertility-sparing treatment in advanced borderline ovarian tumors. an analysis from the mito14 study database
|
Falcone, Francesca |
|
|
30 |
S4 |
p. A46-A47 |
artikel |
79 |
423 Fibronectin and periostin as prognostic markers in ovarian cancer
|
Kujawa, Katarzyna A |
|
|
30 |
S4 |
p. A80-A81 |
artikel |
80 |
418 First real-world hematologic adverse events experience with niraparib in advanced ovarian cancer
|
Wang, Junjian |
|
|
30 |
S4 |
p. A79-A80 |
artikel |
81 |
444 Genomic and functional characterisation of intra-tumoural heterogeneity in high grade serous ovarian cancer
|
Cunnea, Paula |
|
|
30 |
S4 |
p. A98-A99 |
artikel |
82 |
428 Genomic instability metric concordance between oncoscan™, cytosnp and an fda-approved HRD test
|
Cristescu, Razvan |
|
|
30 |
S4 |
p. A130-A131 |
artikel |
83 |
242 #Goasco20: success of a new twitter hashtag to promote gynaecological oncology specific information during asco 2020 virtual annual meeting
|
Bhandoria, Geetu |
|
|
30 |
S4 |
p. A50-A51 |
artikel |
84 |
278 Gynaecologic and non-gynaecologic tumors metastatic to the ovaries
|
Ziyadova, Gunel |
|
|
30 |
S4 |
p. A51-A52 |
artikel |
85 |
491 Have we improved uterine serous carcinomas management the last two decades? A single center experience
|
Liontos, Michail |
|
|
30 |
S4 |
p. A43 |
artikel |
86 |
203 High expression of nanog and CRY1 is involved with tumor progression and poor prognosis in patients with cervical cancer
|
Han, Gwan Hee |
|
|
30 |
S4 |
p. A7 |
artikel |
87 |
425 Hipec in ovarian cancer: the first case-control study in mexican patients
|
Medina-Castro, Juan Manuel |
|
|
30 |
S4 |
p. A81 |
artikel |
88 |
431 Histopathological results after risk-reducing bilateral salpingo-oophorectomy in BRCA1/2 mutation carriers: single center experience
|
Ehmann, Sarah |
|
|
30 |
S4 |
p. A81-A82 |
artikel |
89 |
493 How to reconstruct an open abdominal wall after necrotizing fasciitis: surgical management in difficult cases
|
Aker, Seda Sahin |
|
|
30 |
S4 |
p. A97-A98 |
artikel |
90 |
445 Impact of age on cancer specific survival in patients with locally advanced cervical cancer
|
Leon, David Cantu-de |
|
|
30 |
S4 |
p. A17-A18 |
artikel |
91 |
44 Impact of cervical cancer on quality of life and sexual functioning of Filipino patients who underwent definitive chemoradiation in the university of Santo Tomas hospital, manila, philippines
|
Adajar, Erika Lourdes |
|
|
30 |
S4 |
p. A95 |
artikel |
92 |
594 Impact of the covid pandemic on gynaecological cancer surgery – results from the covidsurg gynaecological cancer international study
|
Sundar, Sudha S |
|
|
30 |
S4 |
p. A123-A124 |
artikel |
93 |
360 Impact of treatment modality on survival of figo stage IIB cervical cancer: a propensity-score matching analysis based on impact of treatment modality on survival of figo stage iib cervical cancer: a propensity-score matching analysis based on surveillance, epidemiology, and end results database
|
Tu, Hua |
|
|
30 |
S4 |
p. A13-A14 |
artikel |
94 |
513 Impact of tumour-free margin and lymph node ratio on oncologic outcomes in vulvar cancer- a single institute experience
|
Kalita, Chinmoyee |
|
|
30 |
S4 |
p. A107 |
artikel |
95 |
43 Implementation, practise and experiences of an international online multidisciplinary tumour board (IMDTB) with a cancer centre in northwest region of cameroon
|
Hentsch, Sebastian |
|
|
30 |
S4 |
p. A108-A109 |
artikel |
96 |
485 Incidence of sexual dysfunction among cervical cancer patients in a tertiary medical center treated with chemoradiation from june to december 2019
|
Tubungbanua, Thalia |
|
|
30 |
S4 |
p. A20 |
artikel |
97 |
601 Increased institutional surgical experience in robot-assisted radical hysterectomy for early stage cervical cancer reduces recurrence rate. results from a nationwide study
|
Ekdahl, Linnea |
|
|
30 |
S4 |
p. A116 |
artikel |
98 |
359 Induction chemotherapy for locally advanced cervical cancer – yay or nay?
|
Simões, Pedro |
|
|
30 |
S4 |
p. A12-A13 |
artikel |
99 |
149 Influence of initial volume of cervical cancer on achieving the recommended brachytherapy dose at target volumes
|
Tomasevic, Aleksandar |
|
|
30 |
S4 |
p. A4-A5 |
artikel |
100 |
453 Intra-tumoural electro-chemotherapy (ECT) with bleomycin for palliation of cutaneous recurrence in gynaecological malignancy
|
Rundle, Stuart |
|
|
30 |
S4 |
p. A105 |
artikel |
101 |
79 Is primary chemoradiation a better treatment? A retrospective study of early stage node-positive cervical cancer
|
Zhang, Nan |
|
|
30 |
S4 |
p. A4 |
artikel |
102 |
297 Leap-005: evaluating the safety and efficacy of lenvatinib and pembrolizumab in patients previously treated for ovarian cancer, a multi-cohort phase 2 study
|
Gonzalez-Martin, Antonio |
|
|
30 |
S4 |
p. A64-A65 |
artikel |
103 |
73 Lessons from radiochemotherapy and modern image-guided adaptive brachytherapy followed by hysterectomy
|
Cagetti, Leonel Varela |
|
|
30 |
S4 |
p. A3 |
artikel |
104 |
487 Liquid biopsy for diagnosing ovarian cancer- quantification of cell-free DNA and p53 mutational analysis
|
Rajaram, Shalini |
|
|
30 |
S4 |
p. A84 |
artikel |
105 |
488 Local and systemic changes associated with the innate immune response and immunoregulatory mechanisms responsible for the establishment and progression of invasive cervical carcinoma
|
Kurmyshkina, Olga |
|
|
30 |
S4 |
p. A20-A21 |
artikel |
106 |
520 Long term follow up after diagnosis of gestational trophoblastic disease
|
Freitas, Pedro Corvelo |
|
|
30 |
S4 |
p. A102 |
artikel |
107 |
607 Long-term results of neoadjuvant dose-dense platinum-based chemotherapy in patients with locally advanced cervical cancer
|
Smirnova, Olga |
|
|
30 |
S4 |
p. A117 |
artikel |
108 |
392 Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation: subgroup analysis by risk in the phase III solo1 study
|
Colombo, Nicoletta |
|
|
30 |
S4 |
p. A76-A77 |
artikel |
109 |
470 Malignant ovarian tumors in pregnancy: a case series
|
Azimi, Helena |
|
|
30 |
S4 |
p. A84 |
artikel |
110 |
395 Menopausal symptoms and sexual disorders in epithelial ovarian cancer survivors, a gineco vivrovaire2 study
|
Joly, Florence |
|
|
30 |
S4 |
p. A97 |
artikel |
111 |
434 Metastatic postmolar choriocarcinoma of the skin
|
Dajao, Michelle Lureineil |
|
|
30 |
S4 |
p. A100-A101 |
artikel |
112 |
500 Metformin as a preventive and therapeutic modality in endometrial cancer: a systematic review and meta-analysis of randomized control trials
|
Prodromidou, Anastasia |
|
|
30 |
S4 |
p. A44 |
artikel |
113 |
255 Mirrors trial: minimally invasive robotic surgery, role in optimal debulking ovarian cancer, recovery & survival
|
Uwins, Christina |
|
|
30 |
S4 |
p. A111-A112 |
artikel |
114 |
597 Mismatch repair protein expression defects in endometrioid endometrial adenocarcinoma
|
Brincat, Mark |
|
|
30 |
S4 |
p. A121 |
artikel |
115 |
378 Mucoadhesive bilayer vaginal tablet as a potential adjuvant treatment for cervical cancer
|
Zainol Abidin, Ismin Izwani |
|
|
30 |
S4 |
p. A15 |
artikel |
116 |
588 Neoadjuvant chemotherapy or first line debulking surgery in advanced ovarian cancers
|
Chekman, Chemseddine |
|
|
30 |
S4 |
p. A126-A127 |
artikel |
117 |
422 New challenges in the management and follow-up of molar pregnancy
|
Copos, Anca |
|
|
30 |
S4 |
p. A100 |
artikel |
118 |
469 New variant of reconstructive surgery for advanced vulvar cancer treatment
|
Bubliieva, Olha |
|
|
30 |
S4 |
p. A105 |
artikel |
119 |
571 Niraparib in patients with newly diagnosed advanced ovarian brcam cancer: a post hoc analysis of the prima/engot-ov26/gog-3012 trial
|
Korach, Jacob |
|
|
30 |
S4 |
p. A125-A126 |
artikel |
120 |
510 Niraparib outcomes in brca wild-type platinum sensitive recurrent ovarian cancer: a comparison of real-world data to the nova trial
|
Cartwright, Douglas |
|
|
30 |
S4 |
p. A85-A86 |
artikel |
121 |
296 Non-surgical management of malignant bowel obstruction in advanced ovarian cancer patients – a systematic review and meta-analysis
|
Idaikkadar, Praveena |
|
|
30 |
S4 |
p. A64 |
artikel |
122 |
550 Novel 3D model systems to assess heterogeneity in response to platinum therapy in high grade serous ovarian cancer
|
Ploski, Jennifer |
|
|
30 |
S4 |
p. A99 |
artikel |
123 |
71 Omitting lymphadenectomy in obese endometrial cancer patients undergoing sentinel lymph node mapping: when more is less
|
Kogan, Liron |
|
|
30 |
S4 |
p. A28-A29 |
artikel |
124 |
543 Oncological and fertility outcomes after vaginal radical trachelectomy: single centre retrospective analysis
|
Predanič, Iza Drobne |
|
|
30 |
S4 |
p. A48 |
artikel |
125 |
548 Oncological outcome of sentinel lymph node mapping or comprehensive surgical staging in patients with node-negative intermediate-risk endometrial cancer
|
Siegenthaler, Franziska |
|
|
30 |
S4 |
p. A45 |
artikel |
126 |
318 One-step nucleic acid amplification (OSNA): a big ‘step’ towards a more accurate intra-operative assessment of sentinel lymph node status for early stage endometrial and cervical cancer?
|
Tranoulis, Anastasios |
|
|
30 |
S4 |
p. A26-A27 |
artikel |
127 |
247 Optimising prediction accuracy of complete cytoreduction for high grade serous advanced ovarian cancer patients using nearest-neighbor models
|
Laios, Alexandros |
|
|
30 |
S4 |
p. A58-A59 |
artikel |
128 |
506 Oral metronomic cyclophosphamide in recurrent ovarian cancer: a single centre experience
|
Attianese, Daniela |
|
|
30 |
S4 |
p. A85 |
artikel |
129 |
564 Outcome of fertility sparing surgery in cervical cancer, a national study in Spain: cefer study
|
Ibanez, Blanca Gil |
|
|
30 |
S4 |
p. A49 |
artikel |
130 |
521 PAP smear screening among female patients of the ibn rochd university hospital center: a cross sectional survey
|
Fouad, Asmàa |
|
|
30 |
S4 |
p. A94-A95 |
artikel |
131 |
294 Patient-reported outcomes (PROS) in patients (PTS) receiving niraparib in the prima/engot-ov26/gog-3012 trial
|
Mäenpää, Johanna |
|
|
30 |
S4 |
p. A63-A64 |
artikel |
132 |
386 Patient-reported outcomes (PROS) in the garnet trial in patients (PTS) with advanced or recurrent mismatch repair deficient/microsatelite instability-high (DMMR/MSI-H) endometrial cancer (EC) treated with dostarlimab
|
Kristeleit, Rebecca |
|
|
30 |
S4 |
p. A40-A41 |
artikel |
133 |
204 Performance and diagnostic accuracy of human papillomavirus testing on urine and self-collected vaginal samples in a referral population
|
Cho, Hyun-Woong |
|
|
30 |
S4 |
p. A7 |
artikel |
134 |
47 Performance of cone biopsy excision for treatment of cervical intraepithelial neoplasia
|
Sanad, Ahmad |
|
|
30 |
S4 |
p. A91 |
artikel |
135 |
557 Peritoneal cancer index (PCI) as a predictor of completeness of cytoreduction at primary and interval debulking surgery in advanced ovarian cancer
|
Fagan, Paula |
|
|
30 |
S4 |
p. A88-A89 |
artikel |
136 |
610 Peritoneal carcinomatosis index as a predictor of cytoreductive outcomes in patients with advanced ovarian cancer
|
Yakovleva, Maria |
|
|
30 |
S4 |
p. A128 |
artikel |
137 |
518 Phase 1B trial of monalizumab (NKG2A inhibitor) plus durvalumab: safety and efficacy in patients with metastatic ovarian, cervical, and microsatellite-stable endometrial cancers
|
Banerjee, Susana |
|
|
30 |
S4 |
p. A86-A87 |
artikel |
138 |
362 Phase-specific and lifetime costs of cervical and endometrial cancer among commercially insured patients in the United States
|
Shah, Ruchitbhai |
|
|
30 |
S4 |
p. A37-A38 |
artikel |
139 |
403 Phase 3 trial of tumor treating fields concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: ENGOT-OV50/GOG-329/INNOVATE-3
|
Vergote, Ignace B |
|
|
30 |
S4 |
p. A113 |
artikel |
140 |
401 Population testing and personalised ovarian cancer risk prediction for risk adapted targeted prevention
|
Gaba, Faiza |
|
|
30 |
S4 |
p. A93 |
artikel |
141 |
565 Postoperative outcomes of primary and interval cytoreductive surgery for advanced ovarian cancer registered in the dutch gynecological oncology audit (DGOA)
|
Tewarie, Nishita Baldewpersad |
|
|
30 |
S4 |
p. A89 |
artikel |
142 |
623 P-possum vs ACS–NSQIP: patient understanding of post-operative risks and shared decision
|
Sevinyan, Lusine |
|
|
30 |
S4 |
p. A135 |
artikel |
143 |
613 Predicting lymphedema associated with lymph node dissection in patients who undergo surgery for endometrial cancer: role of demographic and clinical characteristics
|
Shokri, Nazila |
|
|
30 |
S4 |
p. A122 |
artikel |
144 |
533 Predictive role of radiomic for post-operative complications of lymphadenectomy in ec patients
|
Magni, Francesco |
|
|
30 |
S4 |
p. A44-A45 |
artikel |
145 |
230 Preliminary results of anlotinib and niraparib dual therapy evaluation in platinum-resistant recurrent ovarian cancer (ANNIE): a multicenter, single-arm, phase 2 trial
|
Liu, Guochen |
|
|
30 |
S4 |
p. A58 |
artikel |
146 |
553 Preoperative brachytherapy followed by laparoscopic hysterectomy: a new option to consider for early stages cervical cancer in the light of the LACC trial results
|
Beyer, Clemence |
|
|
30 |
S4 |
p. A23 |
artikel |
147 |
168 Preoperative evaluation of lipid markers of malignant epithelial ovarian tumors
|
Iurova, Mariia |
|
|
30 |
S4 |
p. A56-A57 |
artikel |
148 |
430 Preoperative measurement of tumor volume in early cervical cancer. is it reliable?
|
Boria, Felix |
|
|
30 |
S4 |
p. A16-A17 |
artikel |
149 |
337 Primary imiquimod treatment versus surgery for vulvar intraepithelial neoplasia – PITVIN study. Baseline Results of a Randomized Clinical Trial
|
Trutnovsky, Gerda |
|
|
30 |
S4 |
p. A108 |
artikel |
150 |
298 Prognostic factors for localized uterine carcinosarcoma – 18 years of real-world practice of a portuguese cancer centre
|
Bexiga, Catarina |
|
|
30 |
S4 |
p. A34-A35 |
artikel |
151 |
209 Prognostic factors related to recurrence and survival of early stage vulvar squamous cell carcinoma
|
Wang, Yun |
|
|
30 |
S4 |
p. A103 |
artikel |
152 |
583 Prognostic impact of serum inflammatory biomarkers combined with il-6 expression in cervical cancer patients
|
Domenici, Lavinia |
|
|
30 |
S4 |
p. A114-A115 |
artikel |
153 |
486 Prognostic value of pet-ct scan on survival outcomes of advanced-staged ovarian cancer patients treated with neoadjuvant chemotherapy: a prospective study
|
Petousis, Stamatios |
|
|
30 |
S4 |
p. A27 |
artikel |
154 |
413 Prognostic value of the tumor infiltrating lymphocytes and the neutrophil-to-lymphocyte ratio in patients with advanced ovarian cancer
|
Álvarez-Abril, Beatriz |
|
|
30 |
S4 |
p. A78-A79 |
artikel |
155 |
93 Prophylactic human papillomavirus hpv vaccination to prevent recurrence of cervical intraepithelial neoplasia : a meta-analysis
|
Bartels, Helena |
|
|
30 |
S4 |
p. A91 |
artikel |
156 |
468 Racial disparities in patients with covid-19 infection and gynecologic malignancy
|
Lara, Olivia |
|
|
30 |
S4 |
p. A54 |
artikel |
157 |
327 Radical hysterectomy in early cervical cancer: characteristics and outcomes of a large-controlled european population
|
Boria, Felix |
|
|
30 |
S4 |
p. A11 |
artikel |
158 |
306 Rationale and evidence for emerging antibody-drug conjugates in gynecological cancers: effect of online education on clinician knowledge
|
Fisher, Geoff |
|
|
30 |
S4 |
p. A10-A11 |
artikel |
159 |
287 Real-life efficacy of a multi-ingredient coriolus versicolor-based vaginal gel in high-risk hpv patients: interim analysis
|
Gaslain, Yann |
|
|
30 |
S4 |
p. A9-A10 |
artikel |
160 |
405 Real-life response to standard of care in advanced ovarian cancer – an observational multi-national cohort study (RESPONSE)
|
Marth, Christian |
|
|
30 |
S4 |
p. A77-A78 |
artikel |
161 |
281 Real-world-data on platinum outcomes after parp inhibitors progression in high grade serous ovarian cancer patients
|
Salarich, Andrea Plaja |
|
|
30 |
S4 |
p. A60-A61 |
artikel |
162 |
361 Real-world healthcare costs by line of therapy among newly diagnosed cervical cancer patients and cervical cancer patients newly initiating systemic therapies
|
Kebede, Nehemiah |
|
|
30 |
S4 |
p. A14 |
artikel |
163 |
374 Real world prognostic relevance of residual disease and other clinical factors on the progression of disease and death in patients with advanced ovarian cancer in the US
|
Chase, Dana |
|
|
30 |
S4 |
p. A74-A75 |
artikel |
164 |
379 Real world retrospective study of patients with epithelial ovarian cancer: an international comparison
|
Cheeseman, Sue |
|
|
30 |
S4 |
p. A75-A76 |
artikel |
165 |
598 Recurrence and survival after laparoscopy versus laparotomy in early stage endometrial cancer: follow-up five years after a randomised trial
|
Reijntjes, Bianca |
|
|
30 |
S4 |
p. A121-A122 |
artikel |
166 |
447 Recurrence patterns according to time in locally advanced cervical cancer
|
Romero-Mendoza, Abraham |
|
|
30 |
S4 |
p. A19 |
artikel |
167 |
484 Results of surgical treatment of vulvar cancer using reconstructive plastic surgery
|
Dikareva, Elena |
|
|
30 |
S4 |
p. A106-A107 |
artikel |
168 |
600 Retroperitoneal metastatic pelvic adamantinoma: a novel location mimicking ovarian malignancy and review of the current literature
|
Smyth, Sarah Louise |
|
|
30 |
S4 |
p. A124 |
artikel |
169 |
479 Retrospective review of hematological toxicity of chemoradiotherapy in locally advanced cervical cancers
|
Perera, Jananie |
|
|
30 |
S4 |
p. A19-A20 |
artikel |
170 |
339 Rhabdomyosarcoma of the cervix in teenagers – is fertility preservation a feasible option?
|
Buruiana, Felicia Elena |
|
|
30 |
S4 |
p. A12 |
artikel |
171 |
530 Risk factors affecting oncological outcomes in vulvar cancer undergoing primary surgery: case series from a tertiary cancer centre
|
Shylasree, T.s. |
|
|
30 |
S4 |
p. A107 |
artikel |
172 |
94 Risk factors for lymph node metastasis of ovarian, fallopian tube and primary peritoneal cancer in hereditary breast and ovarian cancer syndrome
|
Mitamura, Takashi |
|
|
30 |
S4 |
p. A55 |
artikel |
173 |
346 Risk factors for margin positivity in leep
|
Celik, Ozlem |
|
|
30 |
S4 |
p. A12 |
artikel |
174 |
228 Risk factors for preoperative complications and management with enhanced recovery after primary surgery for women with epithelial ovarian cancer in a single center of china
|
Zhou, Ying |
|
|
30 |
S4 |
p. A57-A58 |
artikel |
175 |
38 Risk of endometrial cancer among women with benign ovarian tumors – a danish nationwide cohort study
|
Reinholdt, Kristian |
|
|
30 |
S4 |
p. A27-A28 |
artikel |
176 |
254 Robotic corpus cancer surgery: ten year mortality data from the UK epicentre in guildford
|
Uwins, Christina |
|
|
30 |
S4 |
p. A31 |
artikel |
177 |
451 Robotic inguinofemoral groin node dissection – modifications to existing robotic technique
|
Shylasree, T.s. |
|
|
30 |
S4 |
p. A104-A105 |
artikel |
178 |
539 Robotic interval debulking surgery for advanced epithelial ovarian cancer. current challenge or future direction? A systematic review
|
Psomiadou, Victoria |
|
|
30 |
S4 |
p. A88 |
artikel |
179 |
555 Robotic radical parametrectomy in patients with undiagnosed invasive cervical cancer: a step by step procedure
|
Hajj, Houssein EL |
|
|
30 |
S4 |
p. A23-A24 |
artikel |
180 |
90 Role of microrna-145 in epithelial ovarian cancer
|
Romero, Carmen |
|
|
30 |
S4 |
p. A54-A55 |
artikel |
181 |
309 Role of three-dimensional transvaginal ultrasound and diffusion-weighted magnetic resonance imaging for assessment of myometrial invasion in patients with low-risk endometrial cancer
|
Diéguez, Núria Carreras |
|
|
30 |
S4 |
p. A35-A36 |
artikel |
182 |
385 Safety and antitumor activity of dostarlimab in patients (PTS) with advanced or recurrent DNA mismatch repair deficient (DMMR) or proficient (MMRP) endometrial cancer (EC): results from the garnet study
|
Oaknin, Ana |
|
|
30 |
S4 |
p. A39-A40 |
artikel |
183 |
462 Safety of bevacizumab therapy in elderly patients with ovarian cancer: an experience from the department of gynaecologic oncology in the university hospital centre Zagreb
|
Katić, Kristina |
|
|
30 |
S4 |
p. A83-A84 |
artikel |
184 |
370 Safety of oncologic surgery without preoperative covid-19 testing in asymptomatic patients
|
Orhan, Nazlı |
|
|
30 |
S4 |
p. A53 |
artikel |
185 |
592 Sentinel lymph node mapping in early-stage cervical cancer using near-infrared fluorescence imaging: a prospective pilot study
|
Tranoulis, Anastasios |
|
|
30 |
S4 |
p. A115-A116 |
artikel |
186 |
72 Sentinel lymph node mapping: the answer to the surgical staging dilemma in elderly patients with endometrial cancer
|
Kogan, Liron |
|
|
30 |
S4 |
p. A29 |
artikel |
187 |
299 Sentinel lymph-node mapping with indocyanine green in endometrial cancer: detection rate and anatomical sites
|
Gedgaudaite, Migle |
|
|
30 |
S4 |
p. A35 |
artikel |
188 |
549 Sentinel lymph node mapping with indocyanine green in robotic-assisted laparoscopic surgery for early endometrial cancer: a population-based cohort study
|
Tranoulis, Anastasios |
|
|
30 |
S4 |
p. A45-A46 |
artikel |
189 |
264 Serum markers and cytokines in patients with ovarian cancer, endometriosis or other benign ovarian tumours
|
Nowak, Marek |
|
|
30 |
S4 |
p. A60 |
artikel |
190 |
144 Sexual function after pelvic radiotherapy: a brief descriptive study in locally advanced cervical cancer patients
|
Sutandar, Yosep |
|
|
30 |
S4 |
p. A95 |
artikel |
191 |
442 Should we really abandon minimally invasive surgery in early-stage cervical cancer? oncological results of laparoscopically assisted radical vaginal hysterectomy
|
Glickman, Ariel Gustavo |
|
|
30 |
S4 |
p. A17 |
artikel |
192 |
483 Should we re-stage after positive sentinel node biopsy on endometrial cancer?
|
Gorostidi, Mikel |
|
|
30 |
S4 |
p. A42-A43 |
artikel |
193 |
419 Signaling pathways related with itgbl1 in ovarian cancer cells
|
Cortez, Alexander J |
|
|
30 |
S4 |
p. A80 |
artikel |
194 |
604 Significant variation in treatment and survival outcomes in stage 2–4 ovarian cancer in england: results from the national ovarian cancer feasibility audit pilot
|
Sundar, Sudha S |
|
|
30 |
S4 |
p. A133-A134 |
artikel |
195 |
523 SOX2 expression in ovarian serous epithelial cancer
|
Conic, Irena |
|
|
30 |
S4 |
p. A87 |
artikel |
196 |
363 Study of neoadjuvant chemotherapy with a carboplatin and taxol followed by chemoradiation versus chemoradiation for locally advanced cervical cancer
|
Hegazy, Hanady |
|
|
30 |
S4 |
p. A14-A15 |
artikel |
197 |
235 Succor cone: is it cervical conization a protective maneuver
|
Chacón, Enrique |
|
|
30 |
S4 |
p. A7-A8 |
artikel |
198 |
163 Supportive function of pegteograstim and pegfilgrastim on chemotherapy-induced neutropenia in ovary cancer patients
|
Kim, Min Kyu |
|
|
30 |
S4 |
p. A90 |
artikel |
199 |
507 Surgical decision making in premenopausal brca carriers considering risk reducing early-salpingectomy or salpingo-oophorectomy: a qualitative study
|
Gaba, Faiza |
|
|
30 |
S4 |
p. A94 |
artikel |
200 |
580 Surgical management of gynecologic cancers during the COVID-19 pandemic
|
Shokri, Nazila |
|
|
30 |
S4 |
p. A119 |
artikel |
201 |
250 Survival implication of pre-treatment imaging tumor dissemination pattern in patients surgically treated for advanced high grade serous ovarian cancer
|
Laios, Alexandros |
|
|
30 |
S4 |
p. A59 |
artikel |
202 |
271 Survival outcomes of patients with clear cell carcinoma cervix: a single institutional retrospective analysis
|
Sudhakaran, Akhilesh CS |
|
|
30 |
S4 |
p. A8-A9 |
artikel |
203 |
373 Systematic literature review of efficacy and safety of first-line maintenance therapy trials in advanced ovarian cancer
|
Guy, Holly |
|
|
30 |
S4 |
p. A73-A74 |
artikel |
204 |
290 Targeting AKT and DNA-PK as a therapeutic strategy in platinum resistant high-grade serous ovarian cancer
|
Rinne, Natasha |
|
|
30 |
S4 |
p. A62 |
artikel |
205 |
331 Testing prediction accuracy of hdu admission following high grade serous advanced ovarian cancer cytoreductive surgery using machine learning methods
|
Laios, Alexandros |
|
|
30 |
S4 |
p. A111 |
artikel |
206 |
334 Testing prediction accuracy of ideal and prolonged length of hospital stay following ovarian cancer cytoreduction using machine learning methods
|
Laios, Alexandros |
|
|
30 |
S4 |
p. A110 |
artikel |
207 |
70 The added value of sentinel node mapping in endometrial cancer
|
Kogan, Liron |
|
|
30 |
S4 |
p. A28 |
artikel |
208 |
336 The effect of endometriosis on the prognosis of ovarian clear cell carcinoma: the jury is still out
|
Buruiana, Felicia Elena |
|
|
30 |
S4 |
p. A68-A69 |
artikel |
209 |
495 The effect of other high-risk HPV types on cervical intraepithelial neoplasia and cancer
|
Aker, Seda Sahin |
|
|
30 |
S4 |
p. A21-A22 |
artikel |
210 |
282 The efficacy of fibrin sealants in reducing the post-operative morbidity after inguino-femoral lymphadenectomy in melanoma and vulval cancer: back to the drawing board?
|
Tranoulis, Anastasios |
|
|
30 |
S4 |
p. A104 |
artikel |
211 |
305 The evolving role of parp inhibitors in newly diagnosed advanced ovarian cancer: the effect of online education on clinician knowledge, competence and confidence
|
Fisher, Geoff |
|
|
30 |
S4 |
p. A65-A66 |
artikel |
212 |
39 The oncologic outcome after fertility-sparing hormonal management more than 9 months treatment for early stage endometrioid endometrial cancer
|
Chae, Su Hyun |
|
|
30 |
S4 |
p. A28 |
artikel |
213 |
119 The positive pelvic lymph nodes in endometrial cancer – histopathological parameters as predictors
|
Mandic, Aljosa |
|
|
30 |
S4 |
p. A30 |
artikel |
214 |
591 The role of hpv genotypes analysis to prevent overtreatment of high-grade CIN
|
Alessia Salamina, M. |
|
|
30 |
S4 |
p. A129 |
artikel |
215 |
426 The role of KI-67, P16 and BCL-2 in the management of cervical neoplasia
|
Copos, Anca |
|
|
30 |
S4 |
p. A16 |
artikel |
216 |
367 The use of real-world evidence from the edinburgh ovarian cancer database to explore a data gap in the prima trial
|
Hollis, Robert L |
|
|
30 |
S4 |
p. A72-A73 |
artikel |
217 |
215 The utility of a personalised risk calculator in gynae-oncology surgery
|
Jones, Sadie |
|
|
30 |
S4 |
p. A50 |
artikel |
218 |
40 Training paramedical staff to perform cervical cancer screening with aid of specially designed video based tutorials and comparative evaluation of HPV versus cytology as triage test among via positive women
|
Mishra, Gauravi |
|
|
30 |
S4 |
p. A3 |
artikel |
219 |
293 Treatment strategies and survival of women with malignant ovarian germ cell tumours – an analysis of the ago-corsett database
|
Hasenburg, Annette |
|
|
30 |
S4 |
p. A62-A63 |
artikel |
220 |
284 Treatment strategies and survival of women with sex cord stroma cell tumours – an analysis of the ago-corsett database
|
Klar, Maximilian |
|
|
30 |
S4 |
p. A61-A62 |
artikel |
221 |
88 Tumour molecular features predict endometrial cancer patients‘ survival after different surgical approaches
|
Dai, Yibo |
|
|
30 |
S4 |
p. A29-A30 |
artikel |
222 |
332 Two-year prognosis estimation of advanced high grade serous ovarian cancer patients using machine learning
|
Laios, Alexandros |
|
|
30 |
S4 |
p. A67-A68 |
artikel |
223 |
497 Urological complications of cervical cancer treatment : Α retrospective analysis of 420 patients
|
Giannoulopoulos, Dimitrios |
|
|
30 |
S4 |
p. A22 |
artikel |
224 |
277 Use of preoperative and intraoperative parameters for decision making in ovarian preservation in endometrial adenocarcinoma
|
Batur, Halise Meltem |
|
|
30 |
S4 |
p. A32-A33 |
artikel |
225 |
112 USP18 promotes cell proliferation and suppressed apoptosis in cervical cancer cells via akt signaling pathway
|
Tellydiao, Wenjing |
|
|
30 |
S4 |
p. A4 |
artikel |
226 |
612 Vaginal radiofrecuency for the treatment of genital atrophy in patients with oncological history in a public hospital. Life after cancer
|
Berrio, Rocio Garcia |
|
|
30 |
S4 |
p. A129-A130 |
artikel |
227 |
475 Vulvar cancer: 20 year of experience from a referral center in mexico
|
Rodríguez Rosales, Yuridia Evangelina |
|
|
30 |
S4 |
p. A106 |
artikel |
228 |
474 Vulvar reconstruction in patients with advanced malignancies
|
Bubliieva, Olha |
|
|
30 |
S4 |
p. A105-A106 |
artikel |
229 |
241 When MDT interdisciplinarity enhances stringency and professional quality; an analysis of multi-disciplinary team conferences
|
Fog, Sigrid Kasper |
|
|
30 |
S4 |
p. A109-A110 |
artikel |
230 |
269 Which dietary and everyday life habits affect endometrial cancer recurrence? the machine gives the answer
|
Wersäll, Ofra Castro |
|
|
30 |
S4 |
p. A32 |
artikel |
231 |
531 12-years results of the Kazakhstan breast cancer screening programme
|
Kaidarova, Dilyara |
|
|
30 |
S4 |
p. A1-A2 |
artikel |